Literature DB >> 27033059

Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer.

Shouping Xu1,2,3, Zhaoxia Wu1, Cungeng Yang3, Lin Ma2, Baolin Qu2, Guangpei Chen3, Weirong Yao2, Shi Wang1, Yaqiang Liu1, X Allen Li3.   

Abstract

OBJECTIVE: To investigate the changes in CT number (CTN) in gross tumour volume (GTV) and organs at risk (OARs) during the course of radiation therapy (RT) for nasopharyngeal cancer (NPC).
METHODS: Daily megavoltage CT (MVCT) data collected from 30 patients with NPC treated with a prescription dose of 70 Gy in 30-33 fractions using helical tomotherapy were retrospectively analyzed. The contours of GTV and OARs on daily MVCTs were obtained by populating the planning contours from planning CT to daily MVCTs with manual editing, if necessary. The changes of GTV and OAR volumes and the histograms of CTN in the GTV and OARs during the course of RT delivery were analyzed.
RESULTS: Volumes of GTV and parotid glands were reduced during the course of radiation treatment, with an average shrinkage rate of 0.23% per day (range, 0.02-0.8%) and 1.2% per day (range, 0.2-2.3%), respectively. The mean CTN changes in GTV and ipsilateral and contralateral parotid glands were reduced by 52 ± 35 HU, 18 ± 20 HU and 17 ± 22 HU, respectively. For GTV, the CTN and GTV volume decreases were found to be correlated with each other (p < 0.0001). No noticeable CTN change was found in the spinal cord and non-specified tissue irradiated with low doses.
CONCLUSION: The CTN changes in GTV and parotids are measurable during the delivery of fractionated radiotherapy for NPC, were associated with the doses received (the number of fractions delivered) and were patient specific. ADVANCES IN KNOWLEDGE: The CTN change during radiotherapy is dose dependent and is measurable for NPC.

Entities:  

Mesh:

Year:  2016        PMID: 27033059      PMCID: PMC5258137          DOI: 10.1259/bjr.20140819

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  34 in total

1.  Quantitative analysis of normal major salivary glands using computed tomography.

Authors:  M S Heo; S C Lee; S S Lee; H M Choi; S C Choi; T W Park
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-08

2.  Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.

Authors:  Mei Feng; Cungeng Yang; Xiaojian Chen; Shouping Xu; Ion Moraru; Jinyi Lang; Christopher Schultz; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

3.  Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.

Authors:  Quentin Diot; Brian Kavanagh; Tracey Schefter; Laurie Gaspar; Kelly Stuhr; Moyed Miften
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-12       Impact factor: 7.038

4.  A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients.

Authors:  Harry C Y Cheng; Vincent W C Wu; Roger K C Ngan; K W Tang; Charlie C L Chan; K H Wong; S K Au; Dora L W Kwong
Journal:  Radiother Oncol       Date:  2012-04-30       Impact factor: 6.280

5.  Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?

Authors:  Pierre Castadot; Xavier Geets; John Aldo Lee; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2011-07-01       Impact factor: 6.280

6.  Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.

Authors:  Pierre Castadot; Xavier Geets; John Aldo Lee; Nicolas Christian; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2010-04-10       Impact factor: 6.280

7.  The effect of temporal HU variations on the uncertainty of dose recalculations performed on MVCT images.

Authors:  J Pukala; S L Meeks; F J Bova; K M Langen
Journal:  Phys Med Biol       Date:  2011-11-24       Impact factor: 3.609

8.  Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases.

Authors:  Christopher C Howells; Michelle A Stinauer; Quentin Diot; David C Westerly; Tracey E Schefter; Brian D Kavanagh; Moyed Miften
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-09       Impact factor: 7.038

9.  Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial.

Authors:  David L Schwartz; Adam S Garden; Shalin J Shah; Gregory Chronowski; Samir Sejpal; David I Rosenthal; Yipei Chen; Yongbin Zhang; Lifei Zhang; Pei-Fong Wong; John A Garcia; K Kian Ang; Lei Dong
Journal:  Radiother Oncol       Date:  2013-01-29       Impact factor: 6.280

10.  Detection and early phase assessment of radiation-induced lung injury in mice using micro-CT.

Authors:  Shigeyoshi Saito; Kenya Murase
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

View more
  3 in total

1.  Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images.

Authors:  Yanxia Liu; Hongyu Shi; Sijuan Huang; Xiaochuan Chen; Huimin Zhou; Hui Chang; Yunfei Xia; Guohua Wang; Xin Yang
Journal:  Quant Imaging Med Surg       Date:  2019-07

2.  In-vivo Comparison of 18F-FLT uptake, CT Number, Tumor Volume in Evaluation of Repopulation during Radiotherapy for Lung cancer.

Authors:  Xiaoli Zhang; Jinming Yu; Chengming Li; Xindong Sun; Xue Meng
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

3.  Structural Variations in Parotid Glands Induced by Radiation Therapy in Patients with Oral Carcinoma Observed on Contrast-Enhanced Computed Tomography.

Authors:  Ichiro Ogura; Yoshihiko Sasaki; Takaaki Oda; Mikiko Sue; Haruka Yamaguchi; Ayako Kameta; Kazuhide Hayama; Makoto Tsuchimochi
Journal:  Pol J Radiol       Date:  2017-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.